Trial Profile
Multicentric study of combination therapy of theophylline and tiotropium in COPD.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Theophylline (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 20 Jan 2012 New trial record